|
19 Mar 2019 |
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study
|
|
19 Mar 2019 |
Alkahest Doses First Subject in Phase 2 Clinical Trial of Lead Candidate in Patients with Severe Alzheimer's Disease
|
|
19 Mar 2019 |
Cytovation Initiates Clinical Development Programme With CyPep-1, a First-in-class Lytic Agent for Tumor Immunotherapy
|
|
19 Mar 2019 |
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
|
|
19 Mar 2019 |
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
|
|
19 Mar 2019 |
Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial
|
|
19 Mar 2019 |
Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis
|
|
19 Mar 2019 |
Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
|
|
19 Mar 2019 |
BioAegis Therapeutics Completes Enrollment in its Phase 1b/2a Dose-Ranging Safety Study of Recombinant Plasma Gelsolin for Community-Acquired Pneumonia
|
|
19 Mar 2019 |
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
|
|
19 Mar 2019 |
IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
|
|
19 Mar 2019 |
Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
|
|
19 Mar 2019 |
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
|
|
19 Mar 2019 |
Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis
|
|
19 Mar 2019 |
AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention
|
|
19 Mar 2019 |
Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion
|
|
19 Mar 2019 |
China National Biotec Group (CNBG) and ImmunoBiology Ltd Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China
|
|
19 Mar 2019 |
Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
|
|
19 Mar 2019 |
U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy
|
|
19 Mar 2019 |
Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer at the Society of Gynecologic Oncology (SGO) 2019 Annual Meeting
|
